Filing Details

Accession Number:
0001209191-21-060424
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-13 19:31:12
Reporting Period:
2021-10-12
Accepted Time:
2021-10-13 19:31:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1619856 Caribou Biosciences Inc. CRBU Biological Products, (No Disgnostic Substances) (2836) 453728228
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1871131 Steven Kanner 2929 7Th Street, Suite 105
Berkeley CA 94710
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-12 99,548 $1.81 199,719 No 4 P Direct
Common Stock Acquisiton 2021-10-12 698 $1.81 200,417 No 4 P Direct
Common Stock Acquisiton 2021-10-12 14,614 $2.69 215,031 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase Common Stock Disposition 2021-10-12 99,548 $0.00 99,548 $1.81
Common Stock Option to purchase Common Stock Disposition 2021-10-12 698 $0.00 698 $1.81
Common Stock Option to purchase Common Stock Disposition 2021-10-12 14,614 $0.00 14,614 $2.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
71,840 2027-07-11 No 4 X Direct
4,879 2028-03-07 No 4 X Direct
132,134 2029-09-30 No 4 X Direct
Footnotes
  1. These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below.
  2. The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021.
  3. This option became fully exercisable on June 30, 2021.
  4. 1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.